Back to
RENAISSANCE TECHNOLOGIES LLC
INM2 quarters
Position history for
RENAISSANCE TECHNOLOGIES LLC's holdings in INMED PHARMACEUTICALS INC
No. Renaissance Technologies exited its INM (Inmed Pharmaceuticals) position in Q4 2025. Its Q3 2025 13F listed 16,800 shares worth $36,792. Renaissance Technologies first reported INM in Q3 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$36,792
Total Shares Change
-16,800
Quarter-by-Quarter History
Other major holders of INM: JANE STREET GROUP, LLC, UBS Group AG, Virtu Financial LLC, CITADEL ADVISORS LLC